These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 794415)

  • 41. Age interference of lymphokine production by lung derived lymphocytes.
    Ganguly R; Lockey RF
    Allerg Immunol (Leipz); 1985; 31(3):203-6. PubMed ID: 2933940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of supernatants from human mixed lymphocyte cultures on the electrophoretic mobility of guinea pig macrophages.
    Balakrishnan K; Hanjan SN; Talwar JP
    Transplantation; 1973 Dec; 16(6):678-80. PubMed ID: 4271113
    [No Abstract]   [Full Text] [Related]  

  • 43. Two migration inhibitory factors with different chromatographic behavior and isoelectric points.
    Remold HG; Mednis AD
    J Immunol; 1977 Jun; 118(6):2015-9. PubMed ID: 325133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible involvement of macrophage-mediated hepatocytotoxicity in chronic active hepatitis: the induction of liver cell injury by culture supernatant of MAF-activated macrophages.
    Mizoguchi Y; Shiba T; Ohnishi F; Monna T; Yamamoto S; Nakai K; Otani S; Morisawa S
    Hepatogastroenterology; 1981 Oct; 28(5):254-7. PubMed ID: 7047339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The induction of macrophage proliferation in vitro by a lymphocyte-produced factor.
    Hadden JW; Sadlik JR; Hadden EM
    J Immunol; 1978 Jul; 121(1):231-8. PubMed ID: 670701
    [No Abstract]   [Full Text] [Related]  

  • 46. Lymphokine-like factors produced by human lymphoid cell lines with B or T cell surface markers.
    Yoshida T; Kuratsuji T; Takada A; Takada Y; Minowada J; Cohen S
    J Immunol; 1976 Aug; 117(2):548-54. PubMed ID: 781133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of in vitro lymphokine synthesis by glucocorticosteroids.
    Wahl SM; Altman LC; Rosenstreich DL
    J Immunol; 1975 Aug; 115(2):476-81. PubMed ID: 1097517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on migration inhibitory factors of non-lymphoid origin.
    Aul C; Badenoch-Jones P; Schneider W; Turk JL
    Immunobiology; 1984 Dec; 167(5):437-51. PubMed ID: 6396223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro modulation of macrophage tumoricidal activity: partial characterization of a macrophage-activating factor(s) in supernatants of NaIO4-treated peritoneal cells.
    Weinberg JB; Hibbs JB
    J Reticuloendothel Soc; 1979 Sep; 26(3):283-93. PubMed ID: 228037
    [No Abstract]   [Full Text] [Related]  

  • 50. Anti-lymphokine antibody. II. Specificity of biological activity.
    Kuratsuji T; Yoshida T; Cohen S
    J Immunol; 1976 Nov; 117(5 Pt.2):1985-91. PubMed ID: 792334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The activation of mononuclear phagocytes in vitro: immunologically mediated enhancement.
    Adams DO; Biesecker JL; Koss LG
    J Reticuloendothel Soc; 1973 Dec; 14(6):550-70. PubMed ID: 4204505
    [No Abstract]   [Full Text] [Related]  

  • 52. Production of MIF-like supernatants by rheumatoid arthritis lymphocytes stimulated by immunoglobulin G.
    Sany J; Mathieu O; Clot J; Mandin J; Serre H
    Rheumatology; 1975; 6():131-8. PubMed ID: 1105742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole.
    Daniels JC; Warren KS; David JR
    J Immunol; 1975 Nov; 115(5):1414-21. PubMed ID: 51891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Partial purification of the cholestatic factor derived from the lymphocytes of tuberculin-sensitized guinea pigs.
    Mizoguchi Y; Ohnishi F; Monna T; Yamamoto S; Morisawa S
    Gastroenterol Jpn; 1981; 16(3):260-7. PubMed ID: 7021301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of chemotactic activity produced in vivo by a cell-mediated immune reaction in the guinea pig.
    POSTLETHWAITE AE; Snyderman R
    J Immunol; 1975 Jan; 114(1 Pt 2):274-8. PubMed ID: 1117129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production of human lymphocyte mediators after activation with periodate or neuraminidase and galactose oxidase.
    Greineder DK; Rocklin RE; David JR
    J Immunol; 1979 Dec; 123(6):2804-7. PubMed ID: 227960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 2-mercaptoethanol in vitro and macrophage migration in normal and sensitized guinea pigs.
    Prokić LM; Vilić IM
    Biomed Pharmacother; 1985; 39(6):330-4. PubMed ID: 3910130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absorption of macrophage aggregating factor by guinea-pig peritoneal exudate cells.
    Badenoch-Jones P; Rouveix B; Turk JL
    Immunology; 1981 May; 43(1):67-73. PubMed ID: 7251051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.
    Mizel SB; Oppenheim JJ; Rosentreich DL
    J Immunol; 1978 May; 120(5):1504-8. PubMed ID: 307016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.